Copertina

Survey Validation of Exercise and Body Composition Testing and Exercise Training Programs for People With Cystic Fibrosis: A Delphi Study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Najlaa Z. Alotaibi, Donald H. Lein, Hon K. Yuen, Ryan A. Harris, Stefanie Krick, Eric P. Plaisance, John D. Lowman
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pediatric Pulmonology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Co‐Design of a Novel Telehealth Exercise Model of Care for Adults With Cystic Fibrosis
di: Megan Poulsen, et al.
Pubblicazione: (2026)

Effects of an Exercise Intervention on Exercise Capacity in Adults With Cystic Fibrosis: A Quasi‐Experimental Study Comparing Individuals Treated With and Without Elexacaftor/Tezacaftor/Ivacaftor
di: Wolfgang Gruber, et al.
Pubblicazione: (2025)

Exploring Exercise as Airway Clearance in Cystic Fibrosis: A Qualitative Study From the ExACT‐CF Feasibility Trial
di: Emily Taylor, et al.
Pubblicazione: (2026)

Peripheral Muscle Function and Body Composition in People With Cystic Fibrosis on Elexacaftor/Tezacaftor/Ivacaftor: A Cross‐Sectional Single‐Centre Study
di: Lauren J. Clayton, et al.
Pubblicazione: (2025)

Tobramycin Pharmacokinetics in Pediatric People With Cystic Fibrosis on Maintenance Azithromycin
di: Chelsea Flora, et al.
Pubblicazione: (2026)

Linaclotide Use for the Treatment of Constipation and Gastrointestinal Symptoms in People With Cystic Fibrosis
di: Lauren N. Kormelink, et al.
Pubblicazione: (2024)

Associations Between Socioeconomic Status and Adherence to Medications in People With Cystic Fibrosis
di: Gabriela R. Oates, et al.
Pubblicazione: (2025)

Roadmap to Global Cystic Fibrosis Care
di: Samya Z. Nasr, et al.
Pubblicazione: (2025)

Acceptability of Telehealth Post‐Pandemic Among Clinicians Across the United States Caring for People With Cystic Fibrosis
di: Jaclyn Davis, et al.
Pubblicazione: (2025)

Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
di: Cindy L. Williams, et al.
Pubblicazione: (2025)

Feeding the Need: A Study on Food Security Among People With Cystic Fibrosis in Turkey
di: Damla Kocaman, et al.
Pubblicazione: (2025)

C‐Reactive Protein Changes in Adult and Pediatric People With Cystic Fibrosis During Treatment of Pulmonary Exacerbations
di: Jonathan B. Zuckerman, et al.
Pubblicazione: (2025)

Plasma Microbial Cell‐Free DNA Metagenomic Next‐Generation Sequencing in People With Cystic Fibrosis
di: Mollie G. Wasserman, et al.
Pubblicazione: (2024)

The Impact of Attention Deficit Hyperactivity Disorder on Home Spirometry and Other Parameters in People With Cystic Fibrosis
di: Aqeem Azam, et al.
Pubblicazione: (2025)

Elexacaftor/Tezacaftor/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis
di: Burcu Uzunoglu, et al.
Pubblicazione: (2025)

Increasing Cystic Fibrosis Knowledge of Parents of Children Diagnosed With the Newborn Screening Program
di: Mine Yüksel Kalyoncu, et al.
Pubblicazione: (2025)

Pathophysiology of Cystic Fibrosis Liver Disease
di: Vania L. Kasper, et al.
Pubblicazione: (2024)

Cystic Fibrosis Year in Review 2024
di: Adrienne P. Savant
Pubblicazione: (2025)

Systematic Review of Nasal Endoscopy Scores in Cystic Fibrosis Patients Treated With Cystic Fibrosis Transmembrane Conductance Regulator Modulators
di: Rebecca Gallardo, et al.
Pubblicazione: (2026)

Implementation of Cystic Fibrosis Responsibility, Independence, Self‐Care, Education Program Enhances Cystic Fibrosis Knowledge in Limited Resource Country: Results From a Randomized Controlled Trial
di: Merve Selcuk Balcı, et al.
Pubblicazione: (2025)

Stakeholder Priorities for Cystic Fibrosis Mental Health Research: A Community and Provider Survey
di: Anna M. Georgiopoulos, et al.
Pubblicazione: (2026)

Molecular Methods to Detect and Quantify Fungal Communities in Cystic Fibrosis Airway Specimens
di: Matthew K. Fought, et al.
Pubblicazione: (2026)

Expanding Cystic Fibrosis Registries to the Rest of the World
di: Lutz Naehrlich
Pubblicazione: (2026)

The Dutch Gastrointestinal Symptom Tracker for People With Cystic Fibrosis: Associations With Anxiety, Depression, and Health‐Related Quality of Life
di: Marieke Verkleij, et al.
Pubblicazione: (2025)

Real World Adverse Effects of Elexacaftor/Tezacaftor/Ivacaftor in People With Cystic Fibrosis Ages 6–11 Years
di: Rebecca S. Pettit, et al.
Pubblicazione: (2025)

Body Image Perceptions and Elexacaftor/Tezacaftor/Ivacaftor (ETI) Use in Adolescents and Young Adults Living With Cystic Fibrosis
di: Emma R. Lyons, et al.
Pubblicazione: (2025)

Disparities in Access to Cystic Fibrosis Therapy Across Countries
di: Bulent Karadag
Pubblicazione: (2026)

“No Words for Feelings”: Alexithymia in Children With Cystic Fibrosis and Their Caregivers
di: Tuğba Şişmanlar Eyüboğlu, et al.
Pubblicazione: (2026)

A Joint Conversation: People With Cystic Fibrosis' Perception of Healthcare Teams' Knowledge, Comfort, and Barriers in Discussing Substance Use
di: Sanaz Vaziri, et al.
Pubblicazione: (2025)

Assessing Dietary Patterns and Composition Among Adults With Cystic Fibrosis Taking Highly Effective Modulator Therapy
di: Julianna Bailey, et al.
Pubblicazione: (2026)

Money Talks (But Do We?): Evaluating Perceptions and Practices of Financial Conversations by Cystic Fibrosis Clinicians
di: Ryan C. Perkins, et al.
Pubblicazione: (2026)

Hospitalizations in Infants and Young Children With Cystic Fibrosis Enrolled in Medicaid
di: Laurie P. Murray, et al.
Pubblicazione: (2025)

E‐Cigarettes and Cystic Fibrosis—Current Perceptions and Future Directions
di: Maryam Sahibqran, et al.
Pubblicazione: (2024)

The Impact of Cystic Fibrosis‐Related Diabetes on Barriers to Self‐Management
di: Rebecca J. Vitale, et al.
Pubblicazione: (2026)

Case Report: Alpha‐Gal Diagnosis in an Adolescent With Cystic Fibrosis
di: Sean Coyne, et al.
Pubblicazione: (2024)

Fueling Health: Overcoming Food Barriers in Cystic Fibrosis Care
di: Brittany A. Wright, et al.
Pubblicazione: (2025)

Current State of Pharmacogenomic Implementation Into Care for Persons With Cystic Fibrosis
di: Emma M. Tillman, et al.
Pubblicazione: (2025)

Patient‐Derived Intestinal Organoids in the Global Cystic Fibrosis Landscape
di: Suzanne Kroes, et al.
Pubblicazione: (2026)

A Tale of Two Infants: Off‐Label Use of Elexacaftor/Tezacaftor/Ivacaftor in Early Cystic Fibrosis Treatment
di: Nour K. Kadouh, et al.
Pubblicazione: (2025)

Prevalence and Distribution of Musculoskeletal Symptoms in Cystic Fibrosis and Impacts on Daily Life
di: Elizabeth Clarke, et al.
Pubblicazione: (2024)